You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Conjunctival and corneal ulcerations: keep a sharp eye on nicorandil
  1. P Trechot1,
  2. M C Bazard2,
  3. N Petitpain3,
  4. F Trechot2,
  5. L Javot3,
  6. K Angioi4
  1. 1Department of Clinical Pharmacology, University Hospital of Nancy, Nancy, France
  2. 2Department of Ophthalmology, University Hospital of Nancy, Nancy, France
  3. 3Regional Pharmacovigilance Center, University Hospital of Nancy, Nancy, France
  4. 4Department of Ophthalmology, University Hospital of Nancy, Vandoeuvre lès Nancy, France
  1. Correspondence to Dr Philippe Trechot, Department of Clinical Pharmacology, University Hospital of Nancy, 54035 Nancy, France; p.trechot{at}chu-nancy.fr

https://doi.org/10.1136/bjophthalmol-2011-301302

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Nicorandil (Adancor, Ikorel, etc) is a vasodilatator that was first used in Japan (1984) and later (1994) in European and Asian countries for the management of angina.

    Nicorandil, a nicotinamide ester, is an association of nitrates and potassium channel activators, thus decreasing both cardiac preload and afterload.

    Neither nitric oxide donors nor potassium channel …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.